Present On Admission Exempt Codes
ICD-10-CM diagnosis codes exempt from POA reporting based on the official FY2026 CMS POA exempt list.
- T46.1X4DBillable
Poisoning by calcium-channel blockers, undetermined, subsequent encounter
- T46.1X4SBillable
Poisoning by calcium-channel blockers, undetermined, sequela
- T46.1X5DBillable
Adverse effect of calcium-channel blockers, subsequent encounter
- T46.1X5SBillable
Adverse effect of calcium-channel blockers, sequela
- T46.1X6DBillable
Underdosing of calcium-channel blockers, subsequent encounter
- T46.1X6SBillable
Underdosing of calcium-channel blockers, sequela
- T46.2X1DBillable
Poisoning by other antidysrhythmic drugs, accidental (unintentional), subsequent encounter
- T46.2X1SBillable
Poisoning by other antidysrhythmic drugs, accidental (unintentional), sequela
- T46.2X2DBillable
Poisoning by other antidysrhythmic drugs, intentional self-harm, subsequent encounter
- T46.2X2SBillable
Poisoning by other antidysrhythmic drugs, intentional self-harm, sequela
- T46.2X3DBillable
Poisoning by other antidysrhythmic drugs, assault, subsequent encounter
- T46.2X3SBillable
Poisoning by other antidysrhythmic drugs, assault, sequela
- T46.2X4DBillable
Poisoning by other antidysrhythmic drugs, undetermined, subsequent encounter
- T46.2X4SBillable
Poisoning by other antidysrhythmic drugs, undetermined, sequela
- T46.2X5DBillable
Adverse effect of other antidysrhythmic drugs, subsequent encounter
- T46.2X5SBillable
Adverse effect of other antidysrhythmic drugs, sequela
- T46.2X6DBillable
Underdosing of other antidysrhythmic drugs, subsequent encounter
- T46.2X6SBillable
Underdosing of other antidysrhythmic drugs, sequela
- T46.3X1DBillable
Poisoning by coronary vasodilators, accidental (unintentional), subsequent encounter
- T46.3X1SBillable
Poisoning by coronary vasodilators, accidental (unintentional), sequela
- T46.3X2DBillable
Poisoning by coronary vasodilators, intentional self-harm, subsequent encounter
- T46.3X2SBillable
Poisoning by coronary vasodilators, intentional self-harm, sequela
- T46.3X3DBillable
Poisoning by coronary vasodilators, assault, subsequent encounter
- T46.3X3SBillable
Poisoning by coronary vasodilators, assault, sequela
- T46.3X4DBillable
Poisoning by coronary vasodilators, undetermined, subsequent encounter
- T46.3X4SBillable
Poisoning by coronary vasodilators, undetermined, sequela
- T46.3X5DBillable
Adverse effect of coronary vasodilators, subsequent encounter
- T46.3X5SBillable
Adverse effect of coronary vasodilators, sequela
- T46.3X6DBillable
Underdosing of coronary vasodilators, subsequent encounter
- T46.3X6SBillable
Underdosing of coronary vasodilators, sequela
- T46.4X1DBillable
Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), subsequent encounter
- T46.4X1SBillable
Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), sequela
- T46.4X2DBillable
Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, subsequent encounter
- T46.4X2SBillable
Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, sequela
- T46.4X3DBillable
Poisoning by angiotensin-converting-enzyme inhibitors, assault, subsequent encounter
- T46.4X3SBillable
Poisoning by angiotensin-converting-enzyme inhibitors, assault, sequela
- T46.4X4DBillable
Poisoning by angiotensin-converting-enzyme inhibitors, undetermined, subsequent encounter
- T46.4X4SBillable
Poisoning by angiotensin-converting-enzyme inhibitors, undetermined, sequela
- T46.4X5DBillable
Adverse effect of angiotensin-converting-enzyme inhibitors, subsequent encounter
- T46.4X5SBillable
Adverse effect of angiotensin-converting-enzyme inhibitors, sequela
- T46.4X6DBillable
Underdosing of angiotensin-converting-enzyme inhibitors, subsequent encounter
- T46.4X6SBillable
Underdosing of angiotensin-converting-enzyme inhibitors, sequela
- T46.5X1DBillable
Poisoning by other antihypertensive drugs, accidental (unintentional), subsequent encounter
- T46.5X1SBillable
Poisoning by other antihypertensive drugs, accidental (unintentional), sequela
- T46.5X2DBillable
Poisoning by other antihypertensive drugs, intentional self-harm, subsequent encounter
- T46.5X2SBillable
Poisoning by other antihypertensive drugs, intentional self-harm, sequela
- T46.5X3DBillable
Poisoning by other antihypertensive drugs, assault, subsequent encounter
- T46.5X3SBillable
Poisoning by other antihypertensive drugs, assault, sequela
- T46.5X4DBillable
Poisoning by other antihypertensive drugs, undetermined, subsequent encounter
- T46.5X4SBillable
Poisoning by other antihypertensive drugs, undetermined, sequela
- T46.5X5DBillable
Adverse effect of other antihypertensive drugs, subsequent encounter
- T46.5X5SBillable
Adverse effect of other antihypertensive drugs, sequela
- T46.5X6DBillable
Underdosing of other antihypertensive drugs, subsequent encounter
- T46.5X6SBillable
Underdosing of other antihypertensive drugs, sequela
- T46.6X1DBillable
Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), subsequent encounter
- T46.6X1SBillable
Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), sequela
- T46.6X2DBillable
Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, subsequent encounter
- T46.6X2SBillable
Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, sequela
- T46.6X3DBillable
Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault, subsequent encounter
- T46.6X3SBillable
Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault, sequela
- T46.6X4DBillable
Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined, subsequent encounter
- T46.6X4SBillable
Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined, sequela
- T46.6X5DBillable
Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounter
- T46.6X5SBillable
Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, sequela
- T46.6X6DBillable
Underdosing of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounter
- T46.6X6SBillable
Underdosing of antihyperlipidemic and antiarteriosclerotic drugs, sequela
- T46.7X1DBillable
Poisoning by peripheral vasodilators, accidental (unintentional), subsequent encounter
- T46.7X1SBillable
Poisoning by peripheral vasodilators, accidental (unintentional), sequela
- T46.7X2DBillable
Poisoning by peripheral vasodilators, intentional self-harm, subsequent encounter
- T46.7X2SBillable
Poisoning by peripheral vasodilators, intentional self-harm, sequela
- T46.7X3DBillable
Poisoning by peripheral vasodilators, assault, subsequent encounter
- T46.7X3SBillable
Poisoning by peripheral vasodilators, assault, sequela
- T46.7X4DBillable
Poisoning by peripheral vasodilators, undetermined, subsequent encounter
- T46.7X4SBillable
Poisoning by peripheral vasodilators, undetermined, sequela
- T46.7X5DBillable
Adverse effect of peripheral vasodilators, subsequent encounter
- T46.7X5SBillable
Adverse effect of peripheral vasodilators, sequela
- T46.7X6DBillable
Underdosing of peripheral vasodilators, subsequent encounter
- T46.7X6SBillable
Underdosing of peripheral vasodilators, sequela
- T46.8X1DBillable
Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), subsequent encounter
- T46.8X1SBillable
Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), sequela
- T46.8X2DBillable
Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, subsequent encounter
- T46.8X2SBillable
Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, sequela
- T46.8X3DBillable
Poisoning by antivaricose drugs, including sclerosing agents, assault, subsequent encounter
- T46.8X3SBillable
Poisoning by antivaricose drugs, including sclerosing agents, assault, sequela
- T46.8X4DBillable
Poisoning by antivaricose drugs, including sclerosing agents, undetermined, subsequent encounter
- T46.8X4SBillable
Poisoning by antivaricose drugs, including sclerosing agents, undetermined, sequela
- T46.8X5DBillable
Adverse effect of antivaricose drugs, including sclerosing agents, subsequent encounter
- T46.8X5SBillable
Adverse effect of antivaricose drugs, including sclerosing agents, sequela
- T46.8X6DBillable
Underdosing of antivaricose drugs, including sclerosing agents, subsequent encounter
- T46.8X6SBillable
Underdosing of antivaricose drugs, including sclerosing agents, sequela
- T46.901DBillable
Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), subsequent encounter
- T46.901SBillable
Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), sequela
- T46.902DBillable
Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, subsequent encounter
- T46.902SBillable
Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, sequela
- T46.903DBillable
Poisoning by unspecified agents primarily affecting the cardiovascular system, assault, subsequent encounter
- T46.903SBillable
Poisoning by unspecified agents primarily affecting the cardiovascular system, assault, sequela
- T46.904DBillable
Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, subsequent encounter
- T46.904SBillable
Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, sequela
- T46.905DBillable
Adverse effect of unspecified agents primarily affecting the cardiovascular system, subsequent encounter
- T46.905SBillable
Adverse effect of unspecified agents primarily affecting the cardiovascular system, sequela
